KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by 75 percent. This is a 75 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $8.430 million which beat the analyst consensus estimate of $7.570 million by 11.36 percent. This is a 21.54 percent increase over sales of $6.936 million the same period last year.
KORU Medical Systems Q2 2024 Adj. EPS $(0.01) Beats $(0.04) Estimate, Sales $8.430M Beat $7.570M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.